Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sla Plasschaert"'
Autor:
Sla Plasschaert, Klaas Nico Faber, Edo Vellenga, Smjg Daenen, Esjm de Bont, M Boezen, Ege de Vries, D.M. van der Kolk, WA Kamps
Publikováno v:
Blood. 104:1178-1178
Background: Patients with acute lymphoblastic leukemia (ALL) are treated with different chemotherapeutic drugs, which can be transported by ABC-transporters, including six multidrug resistance-associated proteins (MRPs). New insights suggest that a d
Autor:
Obdeijn IV; Center for Image Sciences, High Field MR Research Group, University Medical Center Utrecht, Utrecht, The Netherlands., Wiegers EC; Center for Image Sciences, High Field MR Research Group, University Medical Center Utrecht, Utrecht, The Netherlands., Alic L; Magnetic Detection and Imaging Group, Technical Medical Center, University of Twente, Enschede, The Netherlands., Plasschaert SLA; Department of Pediatric Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kranendonk MEG; Department of Diagnostic Laboratory, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hoogduin HM; Center for Image Sciences, High Field MR Research Group, University Medical Center Utrecht, Utrecht, The Netherlands., Klomp DWJ; Center for Image Sciences, High Field MR Research Group, University Medical Center Utrecht, Utrecht, The Netherlands., Wijnen JP; Center for Image Sciences, High Field MR Research Group, University Medical Center Utrecht, Utrecht, The Netherlands., Lequin MH; Department of Pediatric Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Radiology and Nuclear Medicine, University of Medical Center Utrecht, Utrecht, The Netherlands.
Publikováno v:
NMR in biomedicine [NMR Biomed] 2024 Jun; Vol. 37 (6), pp. e5122. Date of Electronic Publication: 2024 Feb 18.
Autor:
Mueller S; Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, California, USA., Kline C; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Franson A; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Prados M; Department of Neurosurgery and Pediatrics, University of California, San Francisco, San Francisco, California, USA., Waszak SM; Department of Neurology, University of California, San Francisco, San Francisco, California, USA.; Laboratory of Computational Neuro-Oncology, Swiss Institute for Experimental Cancer Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Plasschaert SLA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Molinaro AM; Division of Biomedical Statistics and Informatics, Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA., Koschmann C; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA., Nazarian J; Research Center for Genetic Medicine, Children's National Health System, Washington, District of Columbia, USA.; Brain Tumor Institute, Children's National Health System, Washington, District of Columbia, USA.; DMG Research Center, Department of Pediatrics, University Children's Hospital, University of Zurich, Zürich, Switzerland.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 May 03; Vol. 26 (Supplement_2), pp. S125-S135.
Autor:
Tolboom N; Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands., Verger A; IADI, INSERM, UMR 1254, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, Nancy, France., Albert NL; Department of Nuclear Medicine, University Hospital of Munich, Munich, Germany., Fraioli F; Institute of Nuclear Medicine, University College London, London, United Kingdom., Guedj E; Département de Médecine Nucléaire, Hôpital de la Timone, CERIMED, Institut Fresnel, Aix Marseille University, APHM, CNRS, Centrale Marseille, Marseille, France., Traub-Weidinger T; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria., Morbelli S; IRCCS Ospedale Policlinico San Martino, Genoa Italy.; Nuclear Medicine Unit, Department of Health Sciences, University of Genoa, Genoa, Italy., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium-University Hospital Essen, Essen, Germany., Zucchetta P; Department of Nuclear Medicine, University Hospital of Padova, Padova, Italy., Plasschaert SLA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Yakushev I; Department of Nuclear Medicine, School of Medicine, Technical University of Munich and Munich Center for Neurosciences-Brain and Mind, Munich, Germany., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Glas M; Division of Clinical Neurooncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences, University Medicine Essen, University Duisburg-Essen and German Cancer Consortium, Essen, Germany., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Cecchin D; Nuclear Medicine Unit, Department of Medicine-DIMED, University Hospital of Padua, Padua, Italy., Barthel H; Department of Nuclear Medicine, Leipzig University Medical Centre, Leipzig, Germany; and., Van Weehaeghe D; Department of Radiology and Nuclear Medicine, Ghent University Hospital, Ghent, Belgium donatienne.vanweehaeghe@uzgent.be.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Feb 01; Vol. 65 (2), pp. 167-173. Date of Electronic Publication: 2024 Feb 01.
Autor:
Lebbink CA; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van den Bos C; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Mathematical Institute Leiden University, The Netherlands and Department of Biomedical Science, Section Medical Statistics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Verrijn Stuart AA; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Lentjes EGWM; Laboratory Clinical Chemistry and Hematology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Plasschaert SLA; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands., van Santen HM; Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Feb 27; Vol. 15 (5). Date of Electronic Publication: 2023 Feb 27.
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment.
Autor:
Hill RM; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne NE1 7RU, UK., Plasschaert SLA; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Timmermann B; Department of Particle Therapy, West German Proton Therapy Centre Essen (WPE), West German Cancer Center (WTZ), University Hospital Essen, 45147 Essen, Germany., Dufour C; Department of Pediatric and Adolescent Oncology, Gustave Roussy, 94800 Villejuif, France., Aquilina K; Department of Neurosurgery, Great Ormond Street Hospital, London WC1N 3JH, UK., Avula S; Department of Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool L12 2AP, UK., Donovan L; UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK., Lequin M; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Pietsch T; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, 53127 Bonn, Germany., Thomale U; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany., Tippelt S; Department of Pediatrics III, Center for Translational Neuro- and Behavioral Sciences (CTNBS), University Hospital of Essen, 45147 Essen, Germany., Wesseling P; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pathology, Amsterdam University Medical Centers/VUmc, 1081 HV Amsterdam, The Netherlands., Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany., Clifford SC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne NE1 7RU, UK., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), 69120 Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Department of Pediatric Oncology and Hematology, Heidelberg University Hospital, 69120 Heidelberg, Germany., Bailey S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne NE1 7RU, UK., Fleischhack G; Department of Pediatrics III, Center for Translational Neuro- and Behavioral Sciences (CTNBS), University Hospital of Essen, 45147 Essen, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Dec 28; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 28.
Autor:
Armandari I; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands.; Department of Histology and Cell Biology, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Sekip Utara, 55281, Yogyakarta, Indonesia., Zomerman WW; Department of Pediatric Oncology and Hematology/Pediatrics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Plasschaert SLA; Princess Máxima Center for Pediatric Oncology, Lundlaan 6, 3584 EA, Utrecht, The Netherlands., Smit MJ; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands., Martini TEI; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands., de Camargo Magalhães ES; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands.; Glial Cell Biology Laboratory, Biomedical Sciences Institute, Federal University of Rio de Janeiro, Rio de Janeiro, 21949-590, Brazil., Hogeling SM; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Rozema-Huizinga GC; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands., Lourens HJ; Department of Experimental Hematology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Meeuwsen-de Boer TGJ; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Scherpen FJG; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., de Bont ESJM; Department of Pediatric Oncology and Hematology/Pediatrics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., Bruggeman SWM; Department of Ageing Biology/ERIBA, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, the Netherlands. s.w.m.bruggeman@umcg.nl.
Publikováno v:
Scientific reports [Sci Rep] 2021 Aug 09; Vol. 11 (1), pp. 16077. Date of Electronic Publication: 2021 Aug 09.
Autor:
Zomerman WW; Departments of Pediatric Oncology and Hematology/Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Plasschaert SLA; Departments of Pediatric Oncology and Hematology/Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands; Princess Máxima Center for Pediatric Oncology, Lundlaan 6, 3584 EA Utrecht, the Netherlands., Conroy S; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Scherpen FJ; Departments of Pediatric Oncology and Hematology/Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Meeuwsen-de Boer TGJ; Departments of Pediatric Oncology and Hematology/Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Lourens HJ; Departments of Pediatric Oncology and Hematology/Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Guerrero Llobet S; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Smit MJ; Departments of Pediatric Oncology and Hematology/Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Slagter-Menkema L; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands; Department of Otorhinolaryngology/Head and Neck Surgery, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Seitz A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Gidding CEM; Department of Pediatric Oncology/Pediatrics, Radboud University Medical Center Nijmegen, Geert Groteplein Zuid 10, 6525 HB Nijmegen, the Netherlands., Hulleman E; Department of Pediatric Oncology/Hematology, Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Wesseling P; Princess Máxima Center for Pediatric Oncology, Lundlaan 6, 3584 EA Utrecht, the Netherlands; Department of Pathology, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Meijer L; Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., van Kempen LC; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands; Department of Pathology, McGill University, 3775 University Street, Montreal, QC H3A 2B4, Canada., van den Berg A; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Warmerdam DO; iPSC CRISPR Center, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Kruyt FAE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Foijer F; iPSC CRISPR Center, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands; ERIBA, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., van Vugt MATM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., den Dunnen WFA; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Hoving EW; Department of Neurosurgery, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands; Princess Máxima Center for Pediatric Oncology, Lundlaan 6, 3584 EA Utrecht, the Netherlands., Guryev V; ERIBA, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., de Bont ESJM; Departments of Pediatric Oncology and Hematology/Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands., Bruggeman SWM; Departments of Pediatric Oncology and Hematology/Pediatrics, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands. Electronic address: s.w.m.bruggeman@umcg.nl.
Publikováno v:
Cell reports [Cell Rep] 2018 Mar 20; Vol. 22 (12), pp. 3206-3216.